FBR Capital Starts Biogen (BIIB) at Market Perform

October 30, 2013 7:54 AM

FBR Capital initiates coverage on Biogen (NASDAQ: BIIB) with a Market Perform. PT $259.00.

Analyst William Tanner, Ph.D comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found